1415559-43-1
1415559-43-1
Chemical Structure
CDK9-IN-1
- CAS No.: 1415559-43-1
- Formula:C26H21N5O4S
- Molecular Weight:499.54
IUPAC Name: N-(5-((6-(3-(1,3-dioxoisoindolin-2-yl)phenyl)pyrimidin-4-yl)amino)-2-methylphenyl)methanesulfonamide
InChIKey: CKUFOBCNTCLXJP-UHFFFAOYSA-N
SMILES: CC1=C(NS(C)(=O)=O)C=C(NC2=NC=NC(C3=CC=CC(N4C(C5=C(C=CC=C5)C4=O)=O)=C3)=C2)C=C1
Biological Activity: CDK9-IN-1 is a novel, selective CDK9 inhibitor for the treatment of HIV infection, with an IC50 of 39 nM for CDK9/CycT1, extracted from reference, compound 87.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
CDK9-IN-1 | 98.99% | CDK9-IN-1 is a novel, selective CDK9 inhibitor for the treatment of HIV infection, with an IC50 of 39 nM for CDK9/CycT1, extracted from reference, compound 87. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
CDK9-IN-1 (Standard) | ≥98% | CDK9-IN-1 (Standard) is the analytical standard of CDK9-IN-1. This product is intended for research and analytical applications. CDK9-IN-1 is a novel, selective CDK9 inhibitor for the treatment of HIV infection, with an IC50 of 39 nM for CDK9/CycT1, extracted from reference, compound 87. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
